DEPLOYDatabase

Company

Cyberdyne

Cyberdyne Inc.

Track CyberdyneGet notified of verified changes
Founded
2004
HQ
Tsukuba, Japan
Status
public (TSE: 7779)

Models

1

Deployments

4

Overview

Cyberdyne Inc. is a Japanese robotics company founded in 2004 by Dr. Yoshiyuki Sankai, professor at the University of Tsukuba, to commercialize the Hybrid Assistive Limb (HAL), a brain-controlled exoskeleton for medical and industrial use. HAL received FDA approval in 2020 and medical device approval in Japan for its small-size model in 2025. The company's exoskeletons are deployed in hospitals and healthcare facilities across Japan, Europe, and the United States for treating patients with spinal cord injuries and neurological disorders.

Verified record

Verified deployments
4 deployments on file
Active incidents
None on file

DEPLOY Intelligence

Market intelligence for physical AI

Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.

Key facts

Robot

HAL (Hybrid Assistive Limb) is a powered exoskeleton that reads bioelectric signals from the user's skin to drive its motors.

Focus

Cybernics company developing assistive exoskeleton technology.

CEO

Yoshiyuki Sankai (Founder, PhD)

Product

HAL (Hybrid Assistive Limb) exoskeleton

Stock

Tokyo Stock Exchange (TYO: 7749)

Fund

0M with Pegasus Tech Ventures for physical AI

FDA approval

October 2020 (HAL for medical use)

Japan medical device approval

January 2025 (small-size HAL)

Data & sources

Web sources

2

2 sources backing this record.View all →

Explainers

Plain-language answers to the questions people ask about Cyberdyne, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.

  • What is an exoskeleton robot and how does it work?

    An exoskeleton is a powered wearable robotic device worn by a human that assists or amplifies the wearer's movement. Exoskeletons are not autonomous robots: the wearer's intent drives every action. The category divides between medical exoskeletons (FDA-cleared for rehabilitation and personal mobility) and industrial exoskeletons (worn by workers to reduce fatigue and injury risk).

Current leadership (1)

Founders (1)

Safety record

No incidents on record for Cyberdyne.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Operated deployments (4)

Operator customers (1)

Recent coverage

Cyberdyne in third-party press

Peer companies